Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
Xiangsheng Liu(Zhejiang Cancer Hospital), Huan Meng(National Center for Nanoscience and Technology)
Cited by 132
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
|Nature Communications|2020|68
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma
|Advanced Materials|2023|65